Biodesix Financial Statements From 2010 to 2024

BDSX Stock  USD 1.35  0.04  3.05%   
Biodesix financial statements provide useful quarterly and yearly information to potential Biodesix investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Biodesix financial statements helps investors assess Biodesix's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Biodesix's valuation are summarized below:
Gross Profit
24.1 M
Profit Margin
(0.67)
Market Capitalization
190.6 M
Enterprise Value Revenue
3.3726
Revenue
65.6 M
We have found one hundred twenty available fundamental signals for Biodesix, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Biodesix prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 105.8 M in 2024. Enterprise Value is likely to drop to about 93.5 M in 2024

Biodesix Total Revenue

42.6 Million

Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 3.2 M or Interest Expense of 6.5 M, as well as many indicators such as Price To Sales Ratio of 2.92, Dividend Yield of 0.0 or PTB Ratio of 34.64. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.
  
Check out the analysis of Biodesix Correlation against competitors.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Biodesix Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets86.1 M99.1 M57.9 M
Slightly volatile
Short and Long Term Debt Total34.7 M60.7 M27.3 M
Slightly volatile
Other Current Liabilities16.6 M29.6 M8.8 M
Slightly volatile
Total Current Liabilities26.5 M33.4 M13.8 M
Slightly volatile
Other Liabilities19.8 M17.3 M24.4 M
Slightly volatile
Property Plant And Equipment Net31.1 M29.6 M6.1 M
Slightly volatile
Current Deferred Revenue307.8 K324 K845.8 K
Slightly volatile
Accounts Payable3.3 M2.9 M1.9 M
Slightly volatile
Cash32.2 M26.3 M17 M
Slightly volatile
Non Current Assets Total41.2 M59.4 M33.3 M
Slightly volatile
Non Currrent Assets Other7.2 M6.9 M1.7 M
Slightly volatile
Other Assets7.2 M6.8 M1.7 M
Slightly volatile
Long Term Debt24.4 M35.2 M22.8 M
Very volatile
Cash And Short Term Investments32.2 M26.3 M17 M
Slightly volatile
Net Receivables7.1 M7.7 M4.1 M
Slightly volatile
Good Will15.1 M17.3 M12.4 M
Slightly volatile
Common Stock Total Equity32.6 K31.1 K10.3 K
Slightly volatile
Common Stock Shares Outstanding86.2 M82.1 M33.3 M
Slightly volatile
Liabilities And Stockholders Equity86.1 M99.1 M57.9 M
Slightly volatile
Non Current Liabilities Total88.8 M61.1 M174.4 M
Slightly volatile
Inventory1.9 M1.6 M1.2 M
Slightly volatile
Other Current Assets4.1 M4.3 M2.9 M
Slightly volatile
Other Stockholder Equity286.9 M424.1 M127.5 M
Slightly volatile
Total Liabilities108 M94.5 M187.7 M
Slightly volatile
Property Plant And Equipment Gross37 M35.2 M6.9 M
Slightly volatile
Total Current Assets45 M39.7 M24.6 M
Slightly volatile
Capital Stock100.8 K96 K22.9 K
Slightly volatile
Non Current Liabilities Other676.4 K712 K21.8 M
Slightly volatile
Intangible Assets9.9 M7.9 M14.6 M
Slightly volatile
Common Stock100.8 K96 K22.9 K
Slightly volatile
Property Plant Equipment10.7 M10.1 M3.4 M
Slightly volatile
Short and Long Term Debt48.5 K51 K8.9 M
Slightly volatile
Short Term Debt527.2 K555 K9.2 M
Slightly volatile
Deferred Long Term Liabilities523.2 K588.6 K640.9 K
Slightly volatile

Biodesix Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income25.9 K16.2 K24.5 K
Very volatile
Depreciation And Amortization3.2 M5.5 M2.3 M
Slightly volatile
Interest Expense6.5 M9.5 M4.4 M
Slightly volatile
Selling General Administrative49.7 M67.8 M35.2 M
Slightly volatile
Selling And Marketing Expenses44.7 M70.7 M35.1 M
Slightly volatile
Total Revenue42.6 M49.1 M29.2 M
Slightly volatile
Gross Profit26.1 M36.1 M19.8 M
Slightly volatile
Other Operating Expenses78.2 M90.4 M54.2 M
Slightly volatile
Research Development12 M10 M9.5 M
Slightly volatile
Cost Of Revenue16.5 M13 M9.5 M
Slightly volatile
Total Operating Expenses61.6 M77.4 M44.7 M
Slightly volatile
Reconciled Depreciation4.1 M5.8 M2.7 M
Slightly volatile
Income Tax Expense5.1 M5.3 M2.3 M
Slightly volatile

Biodesix Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation3.7 M5.4 M1.7 M
Slightly volatile
Begin Period Cash Flow28.5 M43.2 M15.1 M
Slightly volatile
DepreciationM5.5 M2.7 M
Slightly volatile
Other Non Cash Items7.8 M7.1 M6.7 M
Slightly volatile
Capital Expenditures24.2 M23.1 M4.2 M
Slightly volatile
Issuance Of Capital Stock41 M56.9 M22.2 M
Slightly volatile
Total Cash From Financing Activities38.9 M29.1 M26.9 M
Slightly volatile
End Period Cash Flow32.3 M26.4 M17.2 M
Slightly volatile
Change To Netincome22.9 M21.8 M9.5 M
Slightly volatile
Sale Purchase Of Stock486.2 K643 K361.3 K
Slightly volatile
Dividends Paid534 K739.5 K390.2 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.923.07812.4003
Slightly volatile
Days Sales Outstanding66.9257.099346.8241
Slightly volatile
Stock Based Compensation To Revenue0.06020.10950.0378
Slightly volatile
Capex To Depreciation4.44.18780.9628
Slightly volatile
EV To Sales3.593.778912.982
Slightly volatile
Inventory Turnover6.769.29297.1868
Slightly volatile
Days Of Inventory On Hand49.3639.277552.1664
Slightly volatile
Payables Turnover5.624.44185.8381
Pretty Stable
Sales General And Administrative To Revenue1.391.441.282
Slightly volatile
Research And Ddevelopement To Revenue0.340.20350.3594
Slightly volatile
Capex To Revenue0.490.46980.0984
Slightly volatile
Cash Per Share0.30.32010.4927
Slightly volatile
Days Payables Outstanding86.3282.174176.2877
Very volatile
Income Quality0.70.43860.6632
Slightly volatile
Intangibles To Total Assets0.450.23150.5698
Slightly volatile
Current Ratio1.931.18752.0113
Slightly volatile
Receivables Turnover8.676.39249.4883
Slightly volatile
Graham Number0.850.89279.9945
Slightly volatile
Capex Per Share0.290.28090.073
Slightly volatile
Revenue Per Share0.570.59780.9116
Pretty Stable
Interest Debt Per Share1.060.54880.9763
Pretty Stable
Debt To Assets0.450.35850.5095
Slightly volatile
Operating Cycle11696.376898.9905
Pretty Stable
Days Of Payables Outstanding86.3282.174176.2877
Very volatile
Ebt Per Ebit1.011.26131.1652
Slightly volatile
Quick Ratio1.841.14561.8888
Slightly volatile
Net Income Per E B T0.891.111.0418
Pretty Stable
Cash Ratio0.980.78661.2575
Pretty Stable
Cash Conversion Cycle21.7914.202722.1581
Slightly volatile
Days Of Inventory Outstanding49.3639.277552.1664
Slightly volatile
Days Of Sales Outstanding66.9257.099346.8241
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio2.112.00841.1846
Slightly volatile
Fixed Asset Turnover1.571.657711.9335
Slightly volatile
Debt Ratio0.450.35850.5095
Slightly volatile
Price Sales Ratio2.923.07812.4003
Slightly volatile
Asset Turnover0.570.49530.5245
Very volatile
Gross Profit Margin0.70.7350.7222
Slightly volatile

Biodesix Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap105.8 M111.4 M302.8 M
Slightly volatile
Enterprise Value93.5 M98.4 M305.3 M
Slightly volatile

Biodesix Fundamental Market Drivers

Cash And Short Term Investments26.3 M

Biodesix Upcoming Events

4th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Biodesix Financial Statements

Biodesix investors use historical fundamental indicators, such as Biodesix's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue324 K307.8 K
Total Revenue49.1 M42.6 M
Cost Of Revenue13 M16.5 M
Stock Based Compensation To Revenue 0.11  0.06 
Sales General And Administrative To Revenue 1.44  1.39 
Research And Ddevelopement To Revenue 0.20  0.34 
Capex To Revenue 0.47  0.49 
Revenue Per Share 0.60  0.57 
Ebit Per Revenue(0.84)(0.88)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.